3Indexed trials
drug · Product Intelligence
200mg SPN-812
Pipeline Intelligence
200mg SPN-812: 3 indexed trials, 1 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.
1Sponsors
0Orange Book patent links
0FDA-linked events
Development evidence
NCT02633527Supernus Pharmaceuticals, Inc. · adhdPHASE2
NCT03247530Supernus Pharmaceuticals, Inc. · adhdPHASE3
NCT03247543Supernus Pharmaceuticals, Inc. · adhdPHASE3
FDA / patent evidence
No FDA Orange Book product match is asserted for this intervention.
Regulatory context
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.